LIGAND PHARMACEUTICALS INC SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZOct 8

   LIGAND PHARMACEUTICALS INC reports insider sales

   • Andrew Reardon sold 340 shares on 10/02/2026 at $52.27
   • Multiple sales occurred on 10/02/2026 with prices ranging from $302.14 to $307.74
   • Reardon is CLO & Secretary of the company

   Andrew Reardon, reporting

2. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZSep 24

   Martine Zimmermann, insider filing for LGNXZ

   Martine Zimmermann, reporting

3. ROUTINE8-KLIGAND PHARMACEUTICALS INCLGNXZSep 24

   Current report

4. ROUTINE8-KLIGAND PHARMACEUTICALS INCLGNXZSep 22

   Current report

5. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZSep 14

   Martine Zimmermann, insider filing for LGNXZ

   Martine Zimmermann, reporting

6. ROUTINE144LIGAND PHARMACEUTICALS INCLGNXZSep 10

   Martine Zimmermann, planned sale of LGNXZ shares

   Martine Zimmermann, reporting

7. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZSep 8

   Andrew Reardon, insider filing for LGNXZ

   Andrew Reardon, reporting

8. ROUTINE144LIGAND PHARMACEUTICALS INCLGNXZSep 3

   Andrew Reardon, planned sale of LGNXZ shares

   Andrew Reardon, reporting

9. ROUTINE8-K/ALIGAND PHARMACEUTICALS INCLGNXZSep 2

   Current report (amended)

10. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZAug 14

    2 insider filings

    Octavio Espinoza, insider filing for LGNXZ

    Show all 2

    • 4Insider filing for LGNXZAug 14
    • 4Insider filing for LGNXZAug 14

    Octavio Espinoza, reporting

11. ROUTINESCHEDULE 13GLIGAND PHARMACEUTICALS INCLGNXZAug 13

    Ownership stake disclosure by Invesco Ltd.

    Invesco Ltd., filed by

12. ROUTINE144LIGAND PHARMACEUTICALS INCLGNXZAug 12

    2 Form 144 notices

    Octavio Espinoza, planned sale of LGNXZ shares

    Show all 2

    • 144Planned insider sale of LGNXZ sharesAug 12
    • 144Planned insider sale of LGNXZ sharesAug 12

    Octavio Espinoza, reporting

13. NOTABLE10-QLIGAND PHARMACEUTICALS INCLGNXZAug 7

    Quarterly report

14. ROUTINE8-KLIGAND PHARMACEUTICALS INCLGNXZAug 6

    Current report

15. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZAug 4

    Andrew Reardon, insider filing for LGNXZ

    Andrew Reardon, reporting

16. ROUTINES-8LIGAND PHARMACEUTICALS INCLGNXZJul 22

    Employee stock plan registration

17. ROUTINE8-KLIGAND PHARMACEUTICALS INCLGNXZJul 14

    Current report

18. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZJul 6

    3 insider filings

    Andrew Reardon, insider filing for LGNXZ

    Show all 3

    • 4Insider filing for LGNXZJul 6
    • 4Insider filing for LGNXZJul 6
    • 4Insider filing for LGNXZJul 6

    Andrew Reardon, reporting

19. ROUTINE144LIGAND PHARMACEUTICALS INCLGNXZJul 1

    Andrew Reardon, planned sale of LGNXZ shares

    Andrew Reardon, reporting

20. ROUTINE8-KLIGAND PHARMACEUTICALS INCLGNXZJun 25

    Current report

21. ROUTINE8-KLIGAND PHARMACEUTICALS INCLGNXZJun 22

    Current report

22. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZJun 18

    Stephen L Sabba, insider filing for LGNXZ

    Stephen L Sabba, reporting

23. ROUTINE144LIGAND PHARMACEUTICALS INCLGNXZJun 16

    Stephen L Sabba, planned sale of LGNXZ shares

    Stephen L Sabba, reporting

24. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZJun 15

    Jason Haas, insider filing for LGNXZ

    Jason Haas, reporting

25. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZJun 12

    2 insider filings

    Jason Aryeh, insider filing for LGNXZ

    Show all 2

    • 4Insider filing for LGNXZJun 12
    • 4Insider filing for LGNXZJun 12

    Jason Aryeh, reporting

26. ROUTINE144LIGAND PHARMACEUTICALS INCLGNXZJun 12

    Jason Haas, planned sale of LGNXZ shares

    Jason Haas, reporting

27. ROUTINE144LIGAND PHARMACEUTICALS INCLGNXZJun 11

    Jason Aryeh, planned sale of LGNXZ shares

    Jason Aryeh, reporting

28. ROUTINE144LIGAND PHARMACEUTICALS INCLGNXZJun 10

    2 Form 144 notices

    Jason Aryeh, planned sale of LGNXZ shares

    Show all 2

    • 144Planned insider sale of LGNXZ sharesJun 10
    • 144Planned insider sale of LGNXZ sharesJun 10

    Jason Aryeh, reporting

29. ROUTINE144LIGAND PHARMACEUTICALS INCLGNXZJun 10

    Jason Aryeh, planned sale of LGNXZ shares

    Jason Aryeh, reporting

30. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZJun 9

    6 insider filings

    Martine Zimmermann, insider filing for LGNXZ

    Show all 6

    • 4Insider filing for LGNXZJun 9
    • 4Insider filing for LGNXZJun 9
    • 4Insider filing for LGNXZJun 9
    • 4Insider filing for LGNXZJun 9
    • 4Insider filing for LGNXZJun 9
    • 4Insider filing for LGNXZJun 9

    Martine Zimmermann, reporting

31. ROUTINE8-KLIGAND PHARMACEUTICALS INCLGNXZJun 9

    Current report

32. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZJun 2

    Andrew Reardon, insider filing for LGNXZ

    Andrew Reardon, reporting

33. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZMay 28

    Octavio Espinoza, insider filing for LGNXZ

    Octavio Espinoza, reporting

34. ROUTINEDEFA14ALIGAND PHARMACEUTICALS INCLGNXZMay 18

    Additional proxy materials

35. ROUTINE8-KLIGAND PHARMACEUTICALS INCLGNXZMay 18

    Current report

36. ROUTINE4LIGAND PHARMACEUTICALS INCLGNXZMay 14

    John W Kozarich, insider filing for LGNXZ

    John W Kozarich, reporting

37. ROUTINE144LIGAND PHARMACEUTICALS INCLGNXZMay 13

    John W Kozarich, planned sale of LGNXZ shares

    John W Kozarich, reporting

38. ROUTINE144LIGAND PHARMACEUTICALS INCLGNXZMay 12

    John W Kozarich, planned sale of LGNXZ shares

    John W Kozarich, reporting

39. NOTABLE10-QLIGAND PHARMACEUTICALS INCLGNXZMay 8

    Quarterly report

Older filings on EDGAR